{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:18:07Z","timestamp":1788020287648,"version":"build-2784847793"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006464","name":"Birla Institute of Technology and Science, Pilani","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.trsl.2026.08.001","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:44:55Z","timestamp":1785912295000},"page":"227-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting TLR4 with ligustrazine and AT1R with telmisartan ameliorates diabetic kidney disease"],"prefix":"10.1016","volume":"296","author":[{"given":"Pratik Shankar","family":"Rakshe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4627-5504","authenticated-orcid":false,"given":"Anil Bhanudas","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2026.08.001_bib0001","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00210-025-04534-9","article-title":"Diabetic kidney disease: exploring mechanistic depths and the future of pharmacological intervention","volume":"399","author":"Rakshe","year":"2025","journal-title":"Naunyn-Schmiedeb Arch Pharmacol"},{"key":"10.1016\/j.trsl.2026.08.001_bib0002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cegh.2020.05.016","article-title":"Diabetic kidney disease: an overview of prevalence, risk factors, and biomarkers","volume":"9","author":"Hussain","year":"2021","journal-title":"Clin Epidemiol Glob Health"},{"issue":"10397","key":"10.1016\/j.trsl.2026.08.001_bib0003","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.001_bib0004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-022-01512-w","article-title":"The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management","volume":"21","author":"Xu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.trsl.2026.08.001_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1264497","article-title":"Treatment and practical considerations of diabetic kidney disease","volume":"10","author":"Bilen","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.trsl.2026.08.001_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118110","article-title":"Ligustrazine as a multitarget scaffold in drug design and discovery","author":"Jiang","year":"2025","journal-title":"Bioorg Med Chem"},{"issue":"1-2","key":"10.1016\/j.trsl.2026.08.001_bib0007","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2012.08.027","article-title":"Development of ligustrazine-loaded lipid emulsion: formulation optimization, characterization and biodistribution","volume":"437","author":"Wei","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.trsl.2026.08.001_bib0008","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-026-08142-w","article-title":"Integrated transcriptomic and metabolomic profiling reveals immune\u2013metabolic crosstalk and predictive biomarkers of ligustrazine treatment response in idiopathic pulmonary fibrosis","author":"Bao","year":"2026","journal-title":"J Transl Med"},{"key":"10.1016\/j.trsl.2026.08.001_bib0009","article-title":"Tetramethylpyrazine enhances neuroprotection and plasticity in cerebral ischemia-reperfusion injury via RhoA\/ROCK2 pathway inhibition","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.001_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3892\/etm.2025.12958","article-title":"Tetramethylpyrazine alleviates acute kidney injury by activating the Wnt\/\u03b2-catenin pathway independent of DKK1","volume":"30","author":"Wang","year":"2025","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.trsl.2026.08.001_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1005014","article-title":"Tetramethylpyrazine ameliorates acute lung injury by regulating the Rac1\/LIMK1 signaling pathway","volume":"13","author":"Min","year":"2023","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.001_bib0012","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0254-6272(09)60002-9","article-title":"Forty-six cases of vertebrobasilar insufficiency treated by acupuncture plus intravenous infusion of ligustrazine","volume":"28","author":"Yan","year":"2008","journal-title":"J Tradit Chin Med"},{"key":"10.1016\/j.trsl.2026.08.001_bib0013","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.12659\/MSM.895362","article-title":"Efficacy of ligustrazine injection as adjunctive therapy for angina pectoris: a systematic review and meta-analysis","volume":"21","author":"Shao","year":"2015","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.001_bib0014","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ptr.3630","article-title":"Effects of ligustrazine on ureteral obstruction-induced renal tubulointerstitial fibrosis","volume":"26","author":"Yuan","year":"2012","journal-title":"Phytother Res"},{"issue":"04","key":"10.1016\/j.trsl.2026.08.001_bib0015","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1142\/S0192415X02000594","article-title":"Effect of tetramethylpyrazine on lipid peroxidation in streptozotocin-induced diabetic mice","volume":"30","author":"Lee","year":"2002","journal-title":"Am J Chin Med"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.001_bib0016","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4103\/1673-5374.156991","article-title":"Ligustrazine monomer against cerebral ischemia\/reperfusion injury","volume":"10","author":"Gao","year":"2015","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.001_bib0017","article-title":"Cardiovascular actions and therapeutic potential of tetramethylpyrazine (active component isolated from Rhizoma Chuanxiong): roles and mechanisms","volume":"2016","author":"Guo","year":"2016","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.001_bib0018","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12951-025-03420-z","article-title":"Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance","volume":"23","author":"Wang","year":"2025","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.001_bib0019","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1007\/s10787-025-01759-1","article-title":"Tetrylpyamethrazine alleviates hepatic fibrosis induced by experimental mansonic schistosomiasis","volume":"33","author":"Dos Santos","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"9","key":"10.1016\/j.trsl.2026.08.001_bib0020","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s12272-018-1089-0","article-title":"Ligustrazine attenuates inflammation and oxidative stress in a rat model of arthritis via the Sirt1\/NF-\u03baB and Nrf-2\/HO-1 pathways","volume":"42","author":"Li","year":"2019","journal-title":"Arch Pharmacal Res"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.001_bib0021","article-title":"Diabetic kidney disease","volume":"71","author":"Gaddy","year":"2025","journal-title":"Dis-A-Mon"},{"key":"10.1016\/j.trsl.2026.08.001_bib0022","series-title":"Chronic Kidney Disease-Novel Insights into Pathophysiology and Treatment","article-title":"Epithelial TGF-\u03b2\/\u03b2-catenin axis in proximal tubule response to chronic kidney disease","author":"Khodo","year":"2024"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.001_bib0023","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/jpc.15884","article-title":"Toll-like receptor inflammatory cascade and the development of diabetic kidney disease in children and adolescents with type 1 diabetes","volume":"58","author":"de Melo","year":"2022","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.001_bib0024","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10787-023-01301-1","article-title":"Ameliorative effect of montelukast against STZ induced diabetic nephropathy: targeting HMGB1, TLR4, NF-\u03baB, NLRP3 inflammasome, and autophagy pathways","volume":"32","author":"Awad","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.001_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ki.2014.271","article-title":"Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy","volume":"87","author":"Shahzad","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.001_bib0026","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ki.2014.322","article-title":"Revisiting inflammation in diabetic nephropathy: the role of the Nlrp3 inflammasome in glomerular resident cells","volume":"87","author":"Sakai","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2026.08.001_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151711","article-title":"Combination of \u03b1-Klotho and telmisartan attenuates diabetic kidney disease via mitigating EMT, inflammation and apoptosis","volume":"760","author":"Gaikwad","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.001_bib0028","first-page":"731","article-title":"Ligustrazine ameliorates acute kidney injury through downregulation of NOD2\u2011mediated inflammation","volume":"45","author":"Jiang","year":"2020","journal-title":"Int J Mol Med"},{"issue":"7","key":"10.1016\/j.trsl.2026.08.001_bib0029","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1745-7254.2005.00141.x","article-title":"Tetramethylpyrazine protected photoreceptor cells of rats by modulating nuclear translocation of NF-\u03baB 1","volume":"26","author":"YANG","year":"2005","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.trsl.2026.08.001_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175528","article-title":"Evaluating the potential of tauroursodeoxycholic acid as add-on therapy in amelioration of streptozotocin-induced diabetic kidney disease","volume":"942","author":"Sankrityayan","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"10.1016\/j.trsl.2026.08.001_bib0031","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/cbin.70078","article-title":"A novel combination of exogenous klotho combined with telmisartan ameliorated diabetic cardiomyopathy via an antifibrotic mechanism","volume":"49","author":"Trivedi","year":"2025","journal-title":"Cell Biol Int"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.001_bib0032","doi-asserted-by":"crossref","first-page":"F518","DOI":"10.1152\/ajprenal.00656.2020","article-title":"A plasma creatinine-and urea-based equation to estimate glomerular filtration rate in rats","volume":"320","author":"Besseling","year":"2021","journal-title":"Am J Physiol-Ren Physiol"},{"key":"10.1016\/j.trsl.2026.08.001_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2026.110317","article-title":"Guaiacol counters renal fibrosis via BMP\/ERK\/Smad1\/5\/9 signalling in UUO-induced chronic kidney disease","author":"Kulkarni","year":"2026","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.trsl.2026.08.001_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118124","article-title":"Levosimendan mitigates renal fibrosis via TGF-\u03b21\/Smad axis modulation in UUO rats","volume":"187","author":"Bhadange","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.trsl.2026.08.001_bib0036","doi-asserted-by":"crossref","first-page":"120975","DOI":"10.1016\/j.jep.2025.120975","article-title":"Exploring the anti-fibrotic potential of gramine in a UUO-induced rat model of chronic kidney disease: a network pharmacology and molecular docking approach with experimental validation","volume":"358","author":"Talati","year":"2025","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.001_bib0037","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/jdi.14360","article-title":"FOSL2 activates TGF-\u03b21-mediated GLUT1\/mTOR signaling to promote diabetic kidney disease","volume":"16","author":"He","year":"2025","journal-title":"J Diabetes Investig"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.001_bib0038","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301579R","article-title":"DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKC\u03b2\/P66shc signaling pathway in diabetic kidney disease","volume":"38","author":"Zhang","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2026.08.001_bib0039","article-title":"Sappanone a prevents diabetic kidney disease by inhibiting kidney inflammation and fibrosis via the NF-\u03baB signaling pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.trsl.2026.08.001_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107044","article-title":"CRISPR\/Cas9 based knockout of lncRNA MALAT1 attenuates TGF-\u03b21 induced Smad 2\/3 mediated fibrosis during AKI-to-CKD transition","volume":"207","author":"Puri","year":"2025","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.trsl.2026.08.001_bib0041","first-page":"1","article-title":"Risedronate attenuates renal fibrosis by targeting prenylation-dependent RhoA\/ROCK1 and ERK\/NF-\u03baB signaling","author":"Bhadange","year":"2025","journal-title":"Naunyn-Schmiedeb Arch Pharmacol"},{"issue":"9","key":"10.1016\/j.trsl.2026.08.001_bib0042","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00204-015-1600-z","article-title":"2, 3, 5, 6-Tetramethylpyrazine (TMP) down-regulated arsenic-induced heme oxygenase-1 and ARS2 expression by inhibiting Nrf2, NF-\u03baB, AP-1 and MAPK pathways in human proximal tubular cells","volume":"90","author":"Gong","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.trsl.2026.08.001_bib0043","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lfs.2019.01.044","article-title":"Telmisartan attenuates diabetic nephropathy progression by inhibiting the dimerization of angiotensin type-1 receptor and adiponectin receptor-1","volume":"221","author":"Zha","year":"2019","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.001_bib0044","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10715762.2024.2313738","article-title":"Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity","volume":"58","author":"Dagar","year":"2024","journal-title":"Free Radic Res"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.001_bib0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12272-022-01374-6","article-title":"Could nutrient supplements provide additional glycemic control in diabetes management? A systematic review and meta-analysis of randomized controlled trials of as an add-on nutritional supplementation therapy","volume":"45","author":"Kim","year":"2022","journal-title":"Arch Pharmacal Res"},{"key":"10.1016\/j.trsl.2026.08.001_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154700","article-title":"Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K\/AKT\/mTOR pathway in diabetic kidney disease","volume":"112","author":"Dong","year":"2023","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.001_bib0047","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1079","article-title":"Tetrahydrocurcumin Add-On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury","volume":"11","author":"Khazaeli","year":"2023","journal-title":"Pharmacol Res Perspect"},{"issue":"7","key":"10.1016\/j.trsl.2026.08.001_bib0048","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/1570180819666220405232333","article-title":"An overview of Tetramethylpyrazine (Ligustrazine) and its derivatives as potent Anti-Alzheimer\u2019s disease agents","volume":"19","author":"Bukhari","year":"2022","journal-title":"Lett Drug Des Discov"},{"key":"10.1016\/j.trsl.2026.08.001_bib0049","first-page":"1","article-title":"Celastrol-Ligustrazine compound proven to be a novel drug candidate for idiopathic pulmonary fibrosis by intervening in the TGF-\u03b21 mediated pathways-an experimental in vitro and vivo study","author":"Gao","year":"2024","journal-title":"Mol Divers"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.001_bib0050","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.21037\/tcr.2020.03.26","article-title":"Ligustrazine eases lung cancer by regulating PTEN and Wnt\/\u03b2-catenin pathway","volume":"9","author":"Dong","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.trsl.2026.08.001_bib0051","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3389\/fphar.2018.00729","article-title":"Ligustrazine exerts cardioprotection in animal models of myocardial ischemia\/reperfusion injury: preclinical evidence and possible mechanisms","volume":"9","author":"Zheng","year":"2018","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.001_bib0052","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024103","article-title":"Salviae miltiorrhizae and ligustrazine hydrochloride injection combined with mecobalamin for treating diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis","volume":"100","author":"Deng","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.trsl.2026.08.001_bib0053","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cytogfr.2025.05.007","article-title":"Exploring inflammatory and fibrotic mechanisms driving diabetic nephropathy progression","volume":"84","author":"Ansari","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"issue":"40","key":"10.1016\/j.trsl.2026.08.001_bib0054","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035397","article-title":"Comprehensive advancements in the prevention and treatment of diabetic nephropathy: a narrative review","volume":"102","author":"Elendu","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.trsl.2026.08.001_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116836","article-title":"Tetramethylpyrazine prevents diabetes by activating PI3K\/Akt\/GLUT-4 signalling in animal model of type-2 diabetes","volume":"236","author":"Rai","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.trsl.2026.08.001_bib0056","article-title":"Telmisartan potentiates insulin secretion via ion channels, independent of the AT1 receptor and PPAR\u03b3","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.trsl.2026.08.001_bib0057","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2026.08.001_bib0058","article-title":"A glimpse of inflammation and anti-inflammation therapy in diabetic kidney disease","volume":"13","author":"Liu","year":"2022","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.001_bib0059","article-title":"The regulation of inflammation by innate and adaptive lymphocytes","volume":"2018","author":"Cronkite","year":"2018","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.001_bib0060","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.molmed.2018.01.004","article-title":"Inflammasome, inflammation, and tissue homeostasis","volume":"24","author":"Rathinam","year":"2018","journal-title":"Trends Mol Med"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.001_bib0061","first-page":"871","volume":"140","author":"Nathan","year":"2010","journal-title":"Nonresolving Inflamm Cell"},{"key":"10.1016\/j.trsl.2026.08.001_bib0062","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jare.2025.07.013","article-title":"Podocyte TLR4 deletion alleviates diabetic kidney disease through prohibiting PKC\u03b4\/SHP-1-dependent ER stress and relieving podocyte damage and inflammation","volume":"82","author":"Li","year":"2026","journal-title":"J Adv Res"},{"key":"10.1016\/j.trsl.2026.08.001_bib0063","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.phrs.2016.11.004","article-title":"Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy","volume":"114","author":"Qiu","year":"2016","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.001_bib0064","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.diabres.2014.04.020","article-title":"Expression and cellular distribution of TLR4, MyD88, and NF-\u03baB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo","volume":"105","author":"Liu","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.001_bib0065","doi-asserted-by":"crossref","first-page":"R410","DOI":"10.1152\/ajpregu.00083.2024","article-title":"Liraglutide ameliorates inflammation and fibrosis by downregulating the TLR4\/MyD88\/NF-\u03baB pathway in diabetic kidney disease","volume":"327","author":"Huang","year":"2024","journal-title":"Am J Physiol-Regul Integr Comp Physiol"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.001_bib0066","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13098-021-00780-y","article-title":"TLR9 regulates NLRP3 inflammasome activation via the NF-kB signaling pathway in diabetic nephropathy","volume":"14","author":"Shen","year":"2022","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.001_bib0067","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12608","article-title":"Metabolic regulation of NLRP 3","volume":"281","author":"Hughes","year":"2018","journal-title":"Immunol Rev"},{"issue":"16","key":"10.1016\/j.trsl.2026.08.001_bib0068","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202400215","article-title":"Isoliquiritigenin alleviates diabetic kidney disease via oxidative stress and the TLR4\/NF-\u03baB\/NLRP3 inflammasome pathway","volume":"68","author":"Wang","year":"2024","journal-title":"Mol Nutr Food Res"},{"issue":"11","key":"10.1016\/j.trsl.2026.08.001_bib0069","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1039\/D3FO01379K","article-title":"Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury","volume":"14","author":"Shelke","year":"2023","journal-title":"Food Funct"},{"key":"10.1016\/j.trsl.2026.08.001_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112601","article-title":"Genistein alleviates renin-angiotensin system mediated vascular and kidney alterations in renovascular hypertensive rats","volume":"146","author":"Poasakate","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.001_bib0071","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s00125-011-2409-9","article-title":"TGF\u03b2 modulates cell-to-cell communication in early epithelial-to-mesenchymal transition","volume":"55","author":"Hills","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.trsl.2026.08.001_bib0072","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.2147\/IJGM.S524138","article-title":"The dual role and therapeutic implications of the Wnt\/\u03b2-catenin pathway in diabetic kidney disease","author":"Adeerjiang","year":"2025","journal-title":"Int J Gen Med"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.001_bib0073","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3892\/mmr.2017.6707","article-title":"Protective effect of berberine on renal fibrosis caused by diabetic nephropathy","volume":"16","author":"Li","year":"2017","journal-title":"Mol Med Rep"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:33:11Z","timestamp":1788017591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426001684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":72,"alternative-id":["S1931524426001684"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.08.001","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting TLR4 with ligustrazine and AT1R with telmisartan ameliorates diabetic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}